These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9780291)

  • 1. Strains of Escherichia coli belonging to serogroups O157 and O55 express lipopolysaccharides that are structurally distinct and do not share common epitopes.
    Bitzan M; Ludwig K
    J Infect Dis; 1998 Nov; 178(5):1551-2. PubMed ID: 9780291
    [No Abstract]   [Full Text] [Related]  

  • 2. Strains of Escherichia coli belonging to serogroups O157 and O55 express lipopolysaccharides that are structurally distinct and do not share common epitopes.
    Chart H; Jenkins C; Smith HR; Rowe B
    J Infect Dis; 1998 Sep; 178(3):920-1. PubMed ID: 9728575
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of usefulness of the enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to lipopolysaccharides of Enterohemorrhagic Escherichia coli (EHEC) strains in patients with gastrointestinal disorders and patients with hemolytic uremic syndrome].
    Med Dosw Mikrobiol; 2014; 66(3-4):161-75. PubMed ID: 25804070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to non-O157 Vero toxin-producing Escherichia coli in patients with hemolytic uremic syndrome.
    Ludwig K; Bitzan M; Zimmermann S; Kloth M; Ruder H; Müller-Wiefel DE
    J Infect Dis; 1996 Nov; 174(5):1028-39. PubMed ID: 8896505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serological response to Verocytotoxigenic Escherichia coli in patients with haemolytic uraemic syndrome.
    Chart H; Perry NT
    Lett Appl Microbiol; 2004; 38(5):351-4. PubMed ID: 15059202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of latex agglutination tests for the detection of human antibodies to the lipopolysaccharides of verocytotoxin-producing Escherichia coli (VTEC) serogroups O157 and non-O157.
    Rastawicki W; Chróst A; Gielarowiec K
    J Microbiol Methods; 2017 Sep; 140():74-76. PubMed ID: 28732694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome in the Czech Republic.
    Bielaszewska M; Janda J; Blahová K; Feber J; Potuzník V; Soucková A
    Clin Nephrol; 1996 Jul; 46(1):42-4. PubMed ID: 8832150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolytic-uremic syndrome and Vero cytotoxin-producing Escherichia coli infection in Italy. The HUS Italian Study Group.
    Caprioli A; Luzzi I; Rosmini F; Pasquini P; Cirrincione R; Gianviti A; Matteucci MC; Rizzoni G
    J Infect Dis; 1992 Jul; 166(1):154-8. PubMed ID: 1607689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Temporal variation of genotypes and serotypes of enterohemorrhagic E Coli isolated from Chilean children with intestinal infections or hemolytic uremic syndrome].
    Prado V; Martínez J; Arellano C; Levine MM
    Rev Med Chil; 1997 Mar; 125(3):291-7. PubMed ID: 9460265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.
    Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM
    Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000.
    Tozzi AE; Caprioli A; Minelli F; Gianviti A; De Petris L; Edefonti A; Montini G; Ferretti A; De Palo T; Gaido M; Rizzoni G;
    Emerg Infect Dis; 2003 Jan; 9(1):106-8. PubMed ID: 12533290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli O157:H7 and the hemolytic-uremic syndrome.
    Boyce TG; Swerdlow DL; Griffin PM
    N Engl J Med; 1995 Aug; 333(6):364-8. PubMed ID: 7609755
    [No Abstract]   [Full Text] [Related]  

  • 13. Escherichia coli O157 fails to induce a long-lasting lipopolysaccharide-specific, measurable humoral immune response in children with hemolytic-uremic syndrome.
    Ludwig K; Bitzan M; Bobrowski C; Müller-Wiefel DE
    J Infect Dis; 2002 Aug; 186(4):566-9. PubMed ID: 12195387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent hemolytic uremic syndrome secondary to Escherichia coli O157:H7 infection.
    Siegler RL; Griffin PM; Barrett TJ; Strockbine NA
    Pediatrics; 1993 Mar; 91(3):666-8. PubMed ID: 8441581
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of hemolytic uremic syndrome caused by Escherichia coli O104:H4.
    Bae WK; Lee YK; Cho MS; Ma SK; Kim SW; Kim NH; Choi KC
    Yonsei Med J; 2006 Jun; 47(3):437-9. PubMed ID: 16807997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Non-O157:H7 Escherichia coli in hemolytic uremic syndrome.
    Goldwater PN; Bettelheim KA
    Clin Infect Dis; 2002 Aug; 35(3):346-7. PubMed ID: 12115108
    [No Abstract]   [Full Text] [Related]  

  • 17. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome.
    Griffin PM; Tauxe RV
    Epidemiol Rev; 1991; 13():60-98. PubMed ID: 1765120
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic evidence of clonal descent of Escherichia coli O157:H7 associated with hemorrhagic colitis and hemolytic uremic syndrome.
    Whittam TS; Wachsmuth IK; Wilson RA
    J Infect Dis; 1988 Jun; 157(6):1124-33. PubMed ID: 3286782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and serologic properties of O-specific polysaccharide from Citrobacter freundii possessing cross-reactivity with Escherichia coli O157:H7.
    Nishiuchi Y; Doe M; Hotta H; Kobayashi K
    FEMS Immunol Med Microbiol; 2000 Jun; 28(2):163-71. PubMed ID: 10799808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome.
    Cimolai N; Basalyga S; Mah DG; Morrison BJ; Carter JE
    Clin Nephrol; 1994 Aug; 42(2):85-9. PubMed ID: 7955583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.